Trial Profile
The Use of Desirudin Versus Heparin for Thrombosis Prophylaxis in Cardiothoracic Surgery Patients.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Desirudin (Primary) ; Heparin
- Indications Thromboembolism
- Focus Therapeutic Use
- 06 Mar 2009 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 06 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 May 2008 Planned end date (Sep 2008) added as reported by ClinicalTrials.gov.